ask="43.49"
ask_size="500"
average_daily_volume="1073850"
bid="39.26"
bid_size="400"
book_value="4.05"
change="+1.87"
change_from_200_day_moving_average="-5.10"
change_from_50_day_moving_average="0.16"
change_from_52_week_high="-13.11"
change_From_52_week_low="10.79"
change_in_percent="+4.66%"
close="42.04"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.68"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-1.76"
ex_dividend_date="N/A"
float_shares="85807000"
high="43.44"
high_52_weeks="55.15"
last_trade_date="1/18/2017"
last_trade_price="42.04"
last_trade_size="620"
last_trade_time="4:00pm"
low="38.84"
low_52_weeks="31.25"
market_capitalization="3.65B"
moving_average_200_day="47.14"
moving_average_50_day="41.88"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.58"
open="39.50"
pe_ratio="N/A"
peg_ratio="0.66"
percent_change_from_200_day_moving_average="-10.82%"
percent_change_from_50_day_moving_average="+0.37%"
percent_change_from_52_week_high="-23.77%"
percent_change_from_52_week_low="+34.53%"
previous_close="40.17"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.92"
price_per_sales="232.64"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.55"
stock_exchange="NMS"
symbol="NBIX"
volume="3426514"
weeks_range_52="31.25 - 55.15"
